ImmunoPrecise Antibodies Ltd. (NASDAQ:IPA) Q3 2026 Earnings Call Transcript March 12, 2026 ImmunoPrecise Antibodies Ltd. misses on earnings expectations. Reported EPS is $-0.06086 EPS, expectations ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results